MedPath

Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring

Not Applicable
Recruiting
Conditions
Atrial Fibrillation
Interventions
Device: FibriCheck recordings
Registration Number
NCT06422468
Lead Sponsor
Qompium NV
Brief Summary

The goal of this interventional clinical trial is to investigate whether combining photoplethysmography (PPG) signals with accelerometer (ACC), gyroscope (GYR), sound, and electrocardiography (ECG) derived smartphone data provides additional insights into the cardiac condition of individuals with and without atrial fibrillation (AF).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
125
Inclusion Criteria

Inclusion criteria applicable for all groups:

  • At least 18 years old
  • Participants must have the ability to understand and provide written informed consent
  • Participants must have the ability to understand Dutch

Group specific inclusion criteria:

Group 1: Healthy volunteers

  • No cardiac conditions based on medical history.

Group 2: Cardiology patients

  • Patients at the consultation or ambulatory unit of Cardiology (pre- cardioversion, pre-pulmonary vein isolation) with AF.
  • Patients without AF but with a current cardiac condition (e.g. heart failure with a reduced or preserved ejection fraction) or a history of a cardiac condition (e.g. history of myocardial infarction).
Exclusion Criteria
  • Individuals with unnaturally coloured fingers (i.e. tattoos, ink); this may weaken the signal and may interfere with the effectiveness of the device
  • Persons with conditions causing tremors or the inability to hold their hand still for at least 60 seconds (e.g. Parkinson or dementia) as, in this case, the device may not be able to accurately process a measurement
  • Persons with reduced blood flow in the fingertips (e.g. perniosis or severe callus formation) as the device may not be able to detect the intensity variations induced by the blood flow
  • Persons that have a disability to perform the measurements according to the instructions for use
  • Persons with cardiac pacemakers, implantable cardioverter-defibrillators, or other implanted electronic devices as these can control the natural heart rhythm

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
FibriCheck recordingsFibriCheck recordings-
Primary Outcome Measures
NameTimeMethod
Identification of morphologic characteristics of smartphone generated signals1 day

Detect or identify specific morphologic characteristics (changes or correlations) by the comparison of PPG signals, accelerometer signals, gyroscope signals, sound signals and ECG signals, derived via the smartphone data.

Secondary Outcome Measures
NameTimeMethod
Evaluate the performance of the FibriCheck Algorithm1 day

Evaluate the performance of our PPG FibriCheck Algorithm in cardiology patients and healthy volunteers, based on simultaneously recorded ECG data (RR intervals).

Trial Locations

Locations (1)

Ziekenhuis Oost Limburg

🇧🇪

Genk, Limburg, Belgium

Ziekenhuis Oost Limburg
🇧🇪Genk, Limburg, Belgium
Pieter Vandervoort, MD
Contact
089/325050
pieter.vandervoort@zol.be
© Copyright 2025. All Rights Reserved by MedPath